JOINT FILING AGREEMENT
Exhibit 99.1
The undersigned hereby agree that this Initial Statement on Schedule 13G with respect to the shares of Common Stock of Iovance Biotherapeutics, Inc., dated as of December 30, 2022, is, and any amendments thereto (including amendments on Schedule 13D) signed by each of the undersigned shall be filed on behalf of each of the undersigned pursuant to and in accordance with the provisions of Rule 13d-1(k) under the Securities Exchange Act of 1934.
Date: December 30, 2022
MHR Capital Partners Master Account LP | ||
By: | /s/ Xxxxx Xxxxx | |
Name:Xxxxx Xxxxx | ||
Title:Authorized Signatory |
MHR ADVISORS LLC | ||
By: | /s/ Xxxxx Xxxxx | |
Name:Xxxxx Xxxxx | ||
Title:Authorized Signatory |
MHRC LLC | ||
By: | /s/ Xxxxx Xxxxx | |
Name:Xxxxx Xxxxx | ||
Title:Authorized Signatory |
MHR FUND MANAGEMENT LLC | ||
By: | /s/ Xxxxx Xxxxx | |
Name:Xxxxx Xxxxx | ||
Title:Authorized Signatory |
MHR HOLDINGS LLC | ||
By: | /s/ Xxxxx Xxxxx | |
Name:Xxxxx Xxxxx | ||
Title:Authorized Signatory |
XXXX X. XXXXXXXX, M.D. | ||
By: | /s/ Xxxxx Xxxxx, Attorney in Fact |